Design and development of novel inhibitors for the treatment of latent tuberculosis
Conclusion Our results indicated that the hit molecule showed activity against both active and persistent forms of infection, which is ideal for new anti-TB agents. This molecule requires further pharmacokinetic and dynamic screening for development as new drug candidate.
Source: International Journal of Mycobacteriology - Category: Infectious Diseases Source Type: research
More News: Infectious Diseases